|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.56 USD | -1.52% |
|
+1.61% | -52.54% |
| 01:20am | Transcript : 10x Genomics, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 04:20 PM | |
| May. 07 | Bruker's NanoString Secures Patent Case Win in Germany | MT |
10x Genomics, Inc. provided revenue guidance for full year 2022. For the period, the company expects revenue guidance of $500 million to $520 million.
| 1st Jan change | Capi. | |
|---|---|---|
| -52.54% | 3.18B | |
| -4.92% | 12.18B | |
| +10.47% | 5.96B | |
| +26.94% | 5.45B | |
| -5.09% | 4.34B | |
| +14.18% | 2.75B | |
| +32.50% | 2.3B | |
| -5.80% | 2.28B | |
| -1.69% | 1.92B | |
| +3.89% | 1.61B |
10X GENOMICS, INC. 